NFKB1 and post-traumatic stress disorder: It was noted in 2022 that a number of breast cancer patients exhibited symptoms similar to those of post-traumatic stress disorder, which were thought to be mediated by chronic inflammation, such as NF-κB, AKt, p53, and other inflammatory pathways (70).